ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 188 filers reported holding ADMA BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $867 | +82.1% | 242,284 | +87.7% | 0.07% | +54.2% |
| Q2 2023 | $476 | +113.5% | 129,100 | +91.3% | 0.05% | +118.2% |
| Q1 2023 | $223 | -65.8% | 67,474 | -59.9% | 0.02% | -72.8% |
| Q4 2022 | $653 | -99.5% | 168,422 | +74.4% | 0.08% | +376.5% |
| Q4 2021 | $136,000 | -80.1% | 96,578 | -84.0% | 0.02% | -75.7% |
| Q3 2021 | $684,000 | -50.3% | 605,237 | -29.7% | 0.07% | -54.8% |
| Q2 2021 | $1,377,000 | +42.4% | 860,911 | +56.6% | 0.16% | -3.1% |
| Q1 2021 | $967,000 | +51.6% | 549,624 | +68.1% | 0.16% | +53.8% |
| Q4 2020 | $638,000 | +14.3% | 327,052 | +40.1% | 0.10% | +11.8% |
| Q3 2020 | $558,000 | +59.9% | 233,425 | +92.5% | 0.09% | +5.7% |
| Q1 2020 | $349,000 | +89.7% | 121,258 | +163.1% | 0.09% | +319.0% |
| Q4 2019 | $184,000 | – | 46,084 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $15,520,000 | 13.71% |
| Stonepine Capital Management, LLC | 6,940,000 | $26,927,200 | 11.33% |
| Caligan Partners LP | 2,676,093 | $10,383,241 | 8.64% |
| Altium Capital Management LP | 2,870,000 | $11,135,600 | 5.66% |
| AWM Investment Company, Inc. | 6,015,000 | $23,338,200 | 3.36% |
| EAM Investors, LLC | 1,749,598 | $6,788,440 | 1.40% |
| Perceptive Advisors | 11,900,255 | $46,172,989 | 1.30% |
| EAM Global Investors LLC | 836,323 | $3,244,933 | 0.84% |
| Potomac Capital Management, Inc. | 120,000 | $466 | 0.54% |
| OBERWEIS ASSET MANAGEMENT INC/ | 536,900 | $2,083,172 | 0.44% |